Keyphrases
Epstein-Barr Virus
100%
Valproic Acid
100%
Lymphoma Cells
100%
Antitumor Activity
100%
Natural Killer
100%
Bortezomib
30%
Natural Killer Cells
30%
Killing Effect
30%
Epstein-Barr Virus-positive
23%
Reduced Cell
15%
Histone Deacetylase Inhibitor (HDACi)
15%
Cell Viability
15%
Jurkat
15%
No Significant Difference
7%
T Cells
7%
Peripheral Blood Mononuclear Cells
7%
Induced Apoptosis
7%
Tumor Cells
7%
B Cells
7%
Cell Cycle Arrest
7%
Anticancer Effect
7%
Antitumor Effect
7%
Lytic Infection
7%
Synergistic Effect
7%
Virus-infected Cell
7%
Acid Activation
7%
Histone Deacetylase 1 (HDAC1)
7%
Protease Inhibitors
7%
Lymphoid Malignancies
7%
Lymphoproliferative Disorders
7%
Uninfected Cells
7%
Acetylated Histone
7%
Medicine and Dentistry
Epstein Barr Virus
100%
Natural Killer Cell Lymphoma
100%
Antineoplastic Activity
100%
Sodium Valproate
100%
Cell Line
30%
Bortezomib
30%
Natural Killer Cell
30%
Histone Deacetylase Inhibitor
15%
Cell Viability
15%
Lymphoma
7%
Tumor Cell
7%
Programmed Cell Death
7%
Infection
7%
Cell Cycle Arrest
7%
T Cell
7%
Peripheral Blood Mononuclear Cell
7%
Histone
7%
B Cell
7%
Lymphoproliferative Disease
7%
Cell Cycle Checkpoint
7%
Histone Deacetylase
7%
Proteasome Inhibitor
7%
Immunology and Microbiology
Antineoplastic Activity
100%
Lymphoma Cell
100%
Epstein Barr Virus
100%
Cell Line
50%
Natural Killer Cell
50%
Cell Viability
25%
B Cell
12%
Cell Cycle Arrest
12%
Tumor Cell
12%
T Cell
12%
Proteasome
12%
Cell Cycle Checkpoint
12%
Peripheral Blood Mononuclear Cell
12%